Literature DB >> 24591220

Coagulation-induced resistance to fluid flow in small-diameter vascular grafts and graft mimics measured by purging pressure.

Michael D Nichols1, Rewa Choudhary, Santhisri Kodali, William M Reichert.   

Abstract

In this study, the coagulation-induced resistance to flow in small-diameter nonpermeable Tygon tubes and permeable expanded polytetrafluoroethylene (ePTFE) vascular grafts was characterized by measuring the upstream pressure needed to purge the coagulum from the tube lumen. This purging pressure was monitored using a closed system that compressed the contents of the tubes at a constant rate. The pressure system was validated using a glycerin series with well-defined viscosities and precisely controlled reductions in cross-sectional area available for flow. This system was then used to systematically probe the upstream pressure buildup as fibrin glue, platelet-rich plasma (PRP) or whole blood coagulated in small-diameter Tygon tubing and or ePTFE grafts. The maximum purging pressures rose with increased clot maturity for fibrin glue, PRP, and whole blood in both Tygon and ePTFE tubes. Although the rapidly coagulating fibrin glue in nonpermeable Tygon tubing yielded highly consistent purging curves, the significantly longer and more variable clotting times of PRP and whole blood, and the porosity of ePTFE grafts, significantly diminished the consistency of the purging curves.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  fibrin; hemocompatibility; test method; thrombogenicity; vascular graft

Mesh:

Substances:

Year:  2013        PMID: 24591220      PMCID: PMC4080422          DOI: 10.1002/jbm.b.32954

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  31 in total

1.  Demography. Broken limits to life expectancy.

Authors:  Jim Oeppen; James W Vaupel
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

2.  Involvement of fibrinogen specific binding in erythrocyte aggregation.

Authors:  David Lominadze; William L Dean
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

3.  Pulmonary vascular resistance. A meaningless variable?

Authors:  Robert Naeije
Journal:  Intensive Care Med       Date:  2003-04       Impact factor: 17.440

4.  Chemical and enzymic detection of protein cross-links. Measurement of epsilon-(gamma-glutamyl)lysine in fibrin polymerized by factor XIII.

Authors:  J J Pisano; J S Finlayson; M P Peyton
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

5.  Amine specificity in transpeptidation. Inhibition of fibrin cross-linking.

Authors:  L Lorand; N G Rule; H H Ong; R Furlanetto; A Jacobsen; J Downey; N Oner; J Bruner-Lorand
Journal:  Biochemistry       Date:  1968-03       Impact factor: 3.162

6.  Activated coagulation time of whole blood.

Authors:  P G Hattersley
Journal:  JAMA       Date:  1966-05-02       Impact factor: 56.272

7.  Comparative kinetics of polymerisation of three fibrin sealants and influence on timing of tissue adhesion.

Authors:  H K Kjaergard; J L Velada; J H Pedersen; H Fleron; D A Hollingsbee
Journal:  Thromb Res       Date:  2000-04-15       Impact factor: 3.944

8.  Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts.

Authors:  Paul S Fleser; Vijay K Nuthakki; Lauren E Malinzak; Rose E Callahan; Marilyn L Seymour; Melissa M Reynolds; Scott I Merz; Mark E Meyerhoff; Phillip J Bendick; Gerald B Zelenock; Charles J Shanley
Journal:  J Vasc Surg       Date:  2004-10       Impact factor: 4.268

9.  The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography.

Authors:  Vance G Nielsen; William Q Gurley; Thomas M Burch
Journal:  Anesth Analg       Date:  2004-07       Impact factor: 5.108

10.  Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation.

Authors:  G W Hamlin; S M Rajah; M J Crow; R C Kester
Journal:  Br J Surg       Date:  1978-04       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.